Palladium hyaluronic acid particles and methods of managing cancer or angiogenic conditions
US12233087B2 · kind B2 · utility
0Cited by
1References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 16, 2019 |
| Grant date | Feb 25, 2025 |
| Priority date | — |
| Expiry date | Apr 3, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08L5/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates to palladium hyaluronic acid particles such as dibenzylideneacetone palladium hyaluronic acid particles. In certain embodiments, this disclosure relates to methods of managing cancer or angiogenic conditions using particles disclosed herein and pharmaceutical compositions comprising the same. In certain embodiments, an objective of this disclosure is hyaluronic acid targeting of CD44, a tumor stem cell marker. In certain embodiments, this disclosure relates to treatment with hyaluronic acid palladium particles disclosed herein for depleting CD44 cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.